MULTI-MUSIQOLS Trial
Cross-source consensus on MULTI-MUSIQOLS Trial from 1 sources and 5 claims.
1 sources · 5 claims
Evidence quality
Other
Other
Highlighted claims
- MULTI-MUSIQOLS is a two-site, three-arm, mixed-methods feasibility randomized controlled trial of music therapy for chronic pain and health-related quality of life in sickle cell disease. — MULTIsite feasibility of MUSIc therapy to address Quality Of Life in Sickle cell disease (MULTI-MUSIQOLS): protocol for a mixed-methods randomised controlled trial at two US medical centres
- The trial focuses on feasibility, acceptability, fidelity, implementation barriers, and data collection rather than clinical efficacy. — MULTIsite feasibility of MUSIc therapy to address Quality Of Life in Sickle cell disease (MULTI-MUSIQOLS): protocol for a mixed-methods randomised controlled trial at two US medical centres
- The study began on April 2, 2025 and is expected to end on January 31, 2027. — MULTIsite feasibility of MUSIc therapy to address Quality Of Life in Sickle cell disease (MULTI-MUSIQOLS): protocol for a mixed-methods randomised controlled trial at two US medical centres
- Ninety participants will be randomized equally into hybrid music therapy, in-person music therapy, or hybrid health education. — MULTIsite feasibility of MUSIc therapy to address Quality Of Life in Sickle cell disease (MULTI-MUSIQOLS): protocol for a mixed-methods randomised controlled trial at two US medical centres
- The protocol will be considered feasible if at least four of six prespecified feasibility thresholds are achieved. — MULTIsite feasibility of MUSIc therapy to address Quality Of Life in Sickle cell disease (MULTI-MUSIQOLS): protocol for a mixed-methods randomised controlled trial at two US medical centres